216 related articles for article (PubMed ID: 27476098)
1. Value of Genetic Testing for the Prediction of Long-Term Outcome in Patients With Hypertrophic Cardiomyopathy.
van Velzen HG; Vriesendorp PA; Oldenburg RA; van Slegtenhorst MA; van der Velden J; Schinkel AFL; Michels M
Am J Cardiol; 2016 Sep; 118(6):881-887. PubMed ID: 27476098
[TBL] [Abstract][Full Text] [Related]
2. Genotype-positive status in patients with hypertrophic cardiomyopathy is associated with higher rates of heart failure events.
Li Q; Gruner C; Chan RH; Care M; Siminovitch K; Williams L; Woo A; Rakowski H
Circ Cardiovasc Genet; 2014 Aug; 7(4):416-22. PubMed ID: 24909666
[TBL] [Abstract][Full Text] [Related]
3. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy.
Mori AA; Castro LR; Bortolin RH; Bastos GM; Oliveira VF; Ferreira GM; Hirata TDC; Fajardo CM; Sampaio MF; Moreira DAR; Pachón-Mateos JC; Correia EB; Sousa AGMR; Brión M; Carracedo A; Hirata RDC; Hirata MH
Forensic Sci Int Genet; 2021 May; 52():102478. PubMed ID: 33588347
[TBL] [Abstract][Full Text] [Related]
4. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.
Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T
Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of Electrocardiographic Patterns at Presentation to Predict Long-term Risk of Cardiac Death in Patients With Hypertrophic Cardiomyopathy.
Biagini E; Pazzi C; Olivotto I; Musumeci B; Limongelli G; Boriani G; Pacileo G; Mastromarino V; Bacchi Reggiani ML; Lorenzini M; Lai F; Berardini A; Mingardi F; Rosmini S; Resciniti E; Borghi C; Autore C; Cecchi F; Rapezzi C
Am J Cardiol; 2016 Aug; 118(3):432-9. PubMed ID: 27289293
[TBL] [Abstract][Full Text] [Related]
6. A founder MYBPC3 mutation results in HCM with a high risk of sudden death after the fourth decade of life.
Calore C; De Bortoli M; Romualdi C; Lorenzon A; Angelini A; Basso C; Thiene G; Iliceto S; Rampazzo A; Melacini P
J Med Genet; 2015 May; 52(5):338-47. PubMed ID: 25740977
[TBL] [Abstract][Full Text] [Related]
7. Effect of Gender and Genetic Mutations on Outcomes in Patients With Hypertrophic Cardiomyopathy.
van Velzen HG; Schinkel AFL; Baart SJ; Huurman R; van Slegtenhorst MA; Kardys I; Michels M
Am J Cardiol; 2018 Dec; 122(11):1947-1954. PubMed ID: 30292335
[TBL] [Abstract][Full Text] [Related]
8. Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy.
Mathew J; Zahavich L; Lafreniere-Roula M; Wilson J; George K; Benson L; Bowdin S; Mital S
Clin Genet; 2018 Feb; 93(2):310-319. PubMed ID: 29053178
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of HCM and long QT syndrome mutations in young sudden cardiac death-related cases.
Allegue C; Gil R; Blanco-Verea A; Santori M; Rodríguez-Calvo M; Concheiro L; Carracedo A; Brion M
Int J Legal Med; 2011 Jul; 125(4):565-72. PubMed ID: 21499742
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis.
Norrish G; Cantarutti N; Pissaridou E; Ridout DA; Limongelli G; Elliott PM; Kaski JP
Eur J Prev Cardiol; 2017 Jul; 24(11):1220-1230. PubMed ID: 28482693
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics and Long-Term Outcome of Hypertrophic Cardiomyopathy in Individuals With a MYBPC3 (Myosin-Binding Protein C) Founder Mutation.
van Velzen HG; Schinkel AFL; Oldenburg RA; van Slegtenhorst MA; Frohn-Mulder IME; van der Velden J; Michels M
Circ Cardiovasc Genet; 2017 Aug; 10(4):. PubMed ID: 28794111
[TBL] [Abstract][Full Text] [Related]
12. Associations Between Female Sex, Sarcomere Variants, and Clinical Outcomes in Hypertrophic Cardiomyopathy.
Lakdawala NK; Olivotto I; Day SM; Han L; Ashley EA; Michels M; Ingles J; Semsarian C; Jacoby D; Jefferies JL; Colan SD; Pereira AC; Rossano JW; Wittekind S; Ware JS; Saberi S; Helms AS; Cirino AL; Leinwand LA; Seidman CE; Ho CY
Circ Genom Precis Med; 2021 Feb; 14(1):e003062. PubMed ID: 33284039
[TBL] [Abstract][Full Text] [Related]
13. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
[TBL] [Abstract][Full Text] [Related]
14. Clinical features, spectrum of causal genetic mutations and outcome of hypertrophic cardiomyopathy in South Africans.
Ntusi NA; Shaboodien G; Badri M; Gumedze F; Mayosi BM
Cardiovasc J Afr; 2016; 27(3):152-158. PubMed ID: 27841901
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy).
Nistri S; Olivotto I; Betocchi S; Losi MA; Valsecchi G; Pinamonti B; Conte MR; Casazza F; Galderisi M; Maron BJ; Cecchi F
Am J Cardiol; 2006 Oct; 98(7):960-5. PubMed ID: 16996883
[TBL] [Abstract][Full Text] [Related]
16. Predictors of Long-Term Outcome in Children with Hypertrophic Cardiomyopathy.
Ziółkowska L; Turska-Kmieć A; Petryka J; Kawalec W
Pediatr Cardiol; 2016 Mar; 37(3):448-58. PubMed ID: 26526335
[TBL] [Abstract][Full Text] [Related]
17. Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy.
Magri D; Agostoni P; Sinagra G; Re F; Correale M; Limongelli G; Zachara E; Mastromarino V; Santolamazza C; Casenghi M; Pacileo G; Valente F; Morosin M; Musumeci B; Pagannone E; Maruotti A; Uguccioni M; Volpe M; Autore C
Int J Cardiol; 2018 Nov; 271():125-131. PubMed ID: 30087038
[TBL] [Abstract][Full Text] [Related]
18. Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy.
Bonaventura J; Rowin EJ; Chan RH; Chin MT; Puchnerova V; Polakova E; Macek M; Votypka P; Batorsky R; Perera G; Koethe B; Veselka J; Maron BJ; Maron MS
J Am Heart Assoc; 2024 May; 13(10):e033565. PubMed ID: 38757491
[TBL] [Abstract][Full Text] [Related]
19. Clinical and ECG variables to predict the outcome of genetic testing in hypertrophic cardiomyopathy.
Robyns T; Breckpot J; Nuyens D; Vandenberk B; Corveleyn A; Kuiperi C; Van Aelst L; Van Cleemput J; Willems R
Eur J Med Genet; 2020 Mar; 63(3):103754. PubMed ID: 31513939
[TBL] [Abstract][Full Text] [Related]
20. Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction.
Desai MY; Bhonsale A; Smedira NG; Naji P; Thamilarasan M; Lytle BW; Lever HM
Circulation; 2013 Jul; 128(3):209-16. PubMed ID: 23770748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
